Literature DB >> 27814964

Changing global policy to deliver safe, equitable, and affordable care for women's cancers.

Ophira Ginsburg1, Rajan Badwe2, Peter Boyle3, Gemma Derricks4, Anna Dare5, Tim Evans6, Alexandru Eniu7, Jorge Jimenez8, Tezer Kutluk9, Gilberto Lopes10, Sulma I Mohammed11, You-Lin Qiao12, Sabina Faiz Rashid13, Diane Summers14, Diana Sarfati15, Marleen Temmerman16, Edward L Trimble17, Aasim I Padela18, Ajay Aggarwal19, Richard Sullivan20.   

Abstract

Breast and cervical cancer are major threats to the health of women globally, particularly in low-income and middle-income countries. Radical progress to close the global cancer divide for women requires not only evidence-based policy making, but also broad multisectoral collaboration that capitalises on recent progress in the associated domains of women's health and innovative public health approaches to cancer care and control. Such multisectoral collaboration can serve to build health systems for cancer, and more broadly for primary care, surgery, and pathology. This Series paper explores the global health and public policy landscapes that intersect with women's health and global cancer control, with new approaches to bringing policy to action. Cancer is a major global social and political priority, and women's cancers are not only a tractable socioeconomic policy target in themselves, but also an important Trojan horse to drive improved cancer control and care.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27814964     DOI: 10.1016/S0140-6736(16)31393-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  User Experience With Low-Cost Virtual Reality Cancer Surgery Simulation in an African Setting.

Authors:  Eric G Bing; Megan L Brown; Anthony Cuevas; Richard Sullivan; Groesbeck P Parham
Journal:  JCO Glob Oncol       Date:  2021-03

Review 2.  The dawn of vaccines for cancer prevention.

Authors:  Olivera J Finn
Journal:  Nat Rev Immunol       Date:  2017-12-27       Impact factor: 53.106

3.  Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review.

Authors:  Alfredo Palacios; Carlos Rojas-Roque; Lucas González; Ariel Bardach; Agustín Ciapponi; Claudia Peckaitis; Andres Pichon-Riviere; Federico Augustovski
Journal:  Pharmacoeconomics       Date:  2021-03-30       Impact factor: 4.981

4.  Women with cancer in low-income countries.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

5.  Breast cancer early detection: A phased approach to implementation.

Authors:  Ophira Ginsburg; Cheng-Har Yip; Ari Brooks; Anna Cabanes; Maira Caleffi; Jorge Antonio Dunstan Yataco; Bishal Gyawali; Valerie McCormack; Myrna McLaughlin de Anderson; Ravi Mehrotra; Alejandro Mohar; Raul Murillo; Lydia E Pace; Electra D Paskett; Anya Romanoff; Anne F Rositch; John R Scheel; Miriam Schneidman; Karla Unger-Saldaña; Verna Vanderpuye; Tsu-Yin Wu; Safina Yuma; Allison Dvaladze; Catherine Duggan; Benjamin O Anderson
Journal:  Cancer       Date:  2020-05-15       Impact factor: 6.860

6.  Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia.

Authors:  Christian Felix Reibold; Wakuma Tariku; Pia Eber-Schulz; Sefonias Getachew; Adamu Addisie; Susanne Unverzagt; Andreas Wienke; Steffen Hauptmann; Claudia Wickenhauser; Martina Vetter; Ahmedin Jemal; Christoph Thomssen; Eva Johanna Kantelhardt
Journal:  Breast Care (Basel)       Date:  2021-01-15       Impact factor: 2.860

7.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

8.  Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.

Authors:  Rebecca Luckett; Neo Mogowa; Howard J Li; Adrienne Erlinger; Michele R Hacker; Katharine Esselen; Sarah Feldman; Roger Shapiro; Chelsea Morroni; Doreen Ramogola-Masire
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

9.  20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.

Authors:  Hong Zhang; Hua-Li Xu; Yu-Chen Wang; Ze-Yuan Lu; Xiao-Feng Yu; Da-Yun Sui
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

Review 10.  Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda.

Authors:  Megan Swanson; Stefanie Ueda; Lee-May Chen; Megan J Huchko; Carol Nakisige; Jane Namugga
Journal:  Gynecol Oncol Rep       Date:  2018-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.